Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gadavist vs Magnevist for CNS MRI in Chinese Patients
NCT00395460Phase 3Completed
- Sponsor
- Bayer
- Start
- Sep 2006
- Primary completion
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of gadobutrol in Central nervous system diseases (2 arms), sponsored by Bayer. Primary endpoint: Change in Contrast to Noise Ratio. Started Sep 2006; status: completed.
02
Drugs
gadobutrol
03
Conditions
Central nervous system diseases
Beyond the preview
Go deeper on NCT00395460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00395460.